Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Taylor Hain"'
Autor:
Lynn Bonham, Darin Davidson, Bailey Donahue, Hailing Lu, Ryan B. O’Malley, Frank J. Hsu, Stanley R. Riddell, Venu G. Pillarisetty, Robin L. Jones, Gabrielle Kane, Edward Y. Kim, Sara Cooper, Seth M. Pollack, Yongwoo D. Seo, Taylor Hain, Lee D. Cranmer, Ernest U. Conrad, Elizabeth T. Loggers
Publikováno v:
Cancer Research. 77:2947-2947
Introduction: Soft tissue sarcomas (STS) are heterogeneous mesenchymal tumors which are both morbid and lethal. G100 is a stable oil-in-water emulsion of glucopyranosyl lipid adjuvant, a highly potent toll-like receptor 4 (TLR4) agonist, which has be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::75b606954ea4b97ede306ec666ec5852
https://doi.org/10.1158/1538-7445.am2017-2947
https://doi.org/10.1158/1538-7445.am2017-2947
Autor:
Lee D. Cranmer, Yongwoo David Seo, Ernest U. Conrad, Elizabeth T. Loggers, Yuexin Xu, Sean Mackay, Frank J. Hsu, Ryan B. O’Malley, Venu G. Pillarisetty, Kevin Morse, Gabrielle Kane, Edward Y. Kim, Stanley R. Riddell, Taylor Hain, Seth M. Pollack, Jing Zhou, Hailing Lu, Jeremy Patino, Robin L. Jones, Jan ter Meulen
Publikováno v:
Journal of Clinical Oncology. 36:71-71
71 Background: Soft tissue sarcomas (STS) are heterogeneous tumors which are morbid and lethal. G100 is under investigation in multiple clinical trials and contains a potent TLR4 agonist (oil-in-water emulsion of glucopyranosyl lipid A) that has been
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bc377313d7448dfbb7d11f4ad7d8f15c
https://doi.org/10.1200/jco.2018.36.5_suppl.71
https://doi.org/10.1200/jco.2018.36.5_suppl.71
Publikováno v:
Directors & Boards. 2022 3rd Quarter, Vol. 46 Issue 5, p50-66. 17p.